10バイアルパック在庫 619%オフRetatrutide 50 mg
GLP-1 / GIP / グルカゴン三作動薬の研究用ペプチド
Retatrutide tri-agonist research peptide, Australian-shipped. Lab-verified ≥99% purity.
研究用途専用。 本化合物は体外研究および実験室用途に限り販売され、人体への摂取や治療目的での使用を意図していません。ご購入をもって、適格な研究者であること、および当社の 免責事項全文に同意したものとみなします。
残り6パック
三受容体作動薬の研究用ペプチド。代謝研究における GLP-1、GIP、グルカゴンシグナル経路への複合作用が検討されています。
Retatrutide is a synthetic tri-agonist research peptide that activates the GLP-1, GIP, and glucagon receptors simultaneously. It is part of a new generation of incretin-receptor research compounds developed to study combined activation of multiple metabolic pathways. Quantum Labs supplies Retatrutide as a lyophilised powder for Australian research applications.
Retatrutide is studied alongside other incretin-receptor agonists — semaglutide (single-agonist GLP-1) and tirzepatide (dual-agonist GLP-1/GIP) — in pre-clinical and clinical research literature. The tri-agonist mechanism is the distinguishing feature that places it in its own research category. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
作用機序
GLP-1、GIP、グルカゴン受容体の同時作動が検討されています。研究では、研究集団における代謝率、満腹感、エネルギー消費マーカーとの関連が報告されています。
純度規格 ≥99% に対して HPLC で検証。認定された第三者ラボが独立して試験しています。
Retatrutide — よくある質問
What is Retatrutide?
Retatrutide is a synthetic tri-agonist research peptide that simultaneously activates the GLP-1, GIP, and glucagon receptors. It is a newer-generation incretin-receptor research compound.
Is Retatrutide legal in Australia?
Retatrutide is not an approved therapeutic in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies Retatrutide for research use only — it is not a substitute for prescription weight-loss medication.
What is the difference between Retatrutide and Tirzepatide?
Tirzepatide is a dual-agonist activating GLP-1 and GIP receptors. Retatrutide is a tri-agonist activating GLP-1, GIP, and glucagon receptors. The added glucagon-receptor activity is the distinguishing pharmacological feature of Retatrutide.
What is the difference between Retatrutide and Mounjaro?
Mounjaro is the brand name for the approved prescription medicine tirzepatide. Retatrutide is a separate research peptide with an additional glucagon-receptor agonism. They are different molecules studied in parallel research literature. Quantum Labs does not supply prescription medicines.
What is the typical Retatrutide research dosage?
Published clinical research has used Retatrutide doses across a wide titration range. Research-protocol dosing varies by model. Human therapeutic dosing is not established. Quantum Labs supplies this compound for laboratory and pre-clinical research use only. It is not represented for human therapeutic use, and questions about clinical dosing, treatment effects, or personal use should be directed to a qualified medical practitioner.
Retatrutide に関連するガイド
研究者はこちらも閲覧しています
10バイアルパック22%オフMOTS-c
凍結乾燥粉末10 mg · 2 strengths
ミトコンドリア由来の代謝ペプチド
2 件のスタックに収録
10バイアルパック17%オフ5-Amino-1MQ
凍結乾燥粉末50 mg · 3 strengths
NNMT 阻害薬の研究化合物
10バイアルパック15%オフL-Carnitine
Sterile solution10 ml × 600 mg/ml
ミトコンドリア脂肪酸トランスポーター
1 件のスタックに収録